Daewon Pharmaceutical Co., Ltd.

KSE 003220.KS

Daewon Pharmaceutical Co., Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 0.53

Daewon Pharmaceutical Co., Ltd. Price to Sales Ratio (P/S) is 0.53 on January 14, 2025, a -11.01% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Daewon Pharmaceutical Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 0.71 on July 17, 2024, which is 34.34% above the current Price to Sales Ratio (P/S).
  • Daewon Pharmaceutical Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 0.50 on December 09, 2024, which is -5.27% below the current Price to Sales Ratio (P/S).
  • Daewon Pharmaceutical Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 0.57.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
KSE: 003220.KS

Daewon Pharmaceutical Co., Ltd.

CEO Mr. Seung-Ryel Baek
IPO Date Sept. 29, 2005
Location South Korea
Headquarters 386 Cheonhodae-ro
Employees 1,260
Sector Health Care
Industries
Description

Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells medicine and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis uses. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. It also exports its products to approximately 45 countries primarily in Asia, Central and South America, the Middle East, etc. The company was founded in 1958 and is headquartered in Seoul, South Korea.

Similar companies

003000.KS

Bukwang Pharmaceutical Co., Ltd.

USD 3.32

0.12%

001360.KS

SAMSUNG PHARM. Co., LTD.

USD 1.04

-1.27%

006280.KS

Green Cross Corporation

USD 108.37

-2.33%

019170.KS

Shin Poong Pharm.Co.,Ltd.

USD 7.51

2.04%

003850.KS

Boryung Corporation

USD 7.02

1.13%

StockViz Staff

January 15, 2025

Any question? Send us an email